| Product Code: ETC7733337 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Bradykinin Mediated Angioedema Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Bradykinin Mediated Angioedema Market - Industry Life Cycle |
3.4 Japan Bradykinin Mediated Angioedema Market - Porter's Five Forces |
3.5 Japan Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Japan Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Japan Bradykinin Mediated Angioedema Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Bradykinin Mediated Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased awareness and diagnosis of bradykinin mediated angioedema in Japan |
4.2.2 Advancements in treatment options and therapies for the condition |
4.2.3 Rising healthcare expenditure and investments in research and development in the healthcare sector in Japan |
4.3 Market Restraints |
4.3.1 High cost of treatment for bradykinin mediated angioedema |
4.3.2 Limited availability of specialized healthcare professionals for the management of the condition in Japan |
4.3.3 Stringent regulatory requirements and approval processes for new treatments in the country |
5 Japan Bradykinin Mediated Angioedema Market Trends |
6 Japan Bradykinin Mediated Angioedema Market, By Types |
6.1 Japan Bradykinin Mediated Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By C1-INH Concentrates, 2021- 2031F |
6.1.4 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Bradykinin B2-Receptor Antagonist, 2021- 2031F |
6.1.5 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Icatibant, 2021- 2031F |
6.1.6 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.7 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Ecallantide, 2021- 2031F |
6.1.8 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Bradykinin Mediated Angioedema Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.3 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Bradykinin Mediated Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Japan Bradykinin Mediated Angioedema Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Japan Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Bradykinin Mediated Angioedema Market Import-Export Trade Statistics |
7.1 Japan Bradykinin Mediated Angioedema Market Export to Major Countries |
7.2 Japan Bradykinin Mediated Angioedema Market Imports from Major Countries |
8 Japan Bradykinin Mediated Angioedema Market Key Performance Indicators |
8.1 Average time to diagnosis of bradykinin mediated angioedema in Japan |
8.2 Number of clinical trials for new therapies targeting bradykinin mediated angioedema |
8.3 Patient adherence and compliance rates to prescribed treatment regimens |
8.4 Healthcare infrastructure development in terms of specialized centers for angioedema treatment |
8.5 Patient-reported outcomes and quality of life improvements following treatment for bradykinin mediated angioedema |
9 Japan Bradykinin Mediated Angioedema Market - Opportunity Assessment |
9.1 Japan Bradykinin Mediated Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Bradykinin Mediated Angioedema Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Japan Bradykinin Mediated Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Japan Bradykinin Mediated Angioedema Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Bradykinin Mediated Angioedema Market - Competitive Landscape |
10.1 Japan Bradykinin Mediated Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Japan Bradykinin Mediated Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here